 "Suven Life rises on receiving product patents in Europe, Macau")
Shares of Suven Life Sciences were up nearly 3% at Rs 269 on the BSE after the company said it has received product patents one each from Europe and Macau corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases.
With these patents, the company now has twenty granted patents from Europe and eight granted patents from Macau, the company said in a release.
The patents are valid through 2030 and 2029, the release added.
The stock opened at Rs 264 and touched a high of Rs 275. At 10:55am, over 850,000 shares were traded on both the stock exchanges
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app